Related Experiment Video

Updated: May 5, 2026

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells
18:30

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells

Published on: February 13, 2013

20.5K

Decreased expression of PIAS1 and PIAS3 in essential thrombocythemia patients

H-H Hsiao1, Y-C Liu, M-Y Yang

  • 1Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

Genetics and Molecular Research : GMR
|December 5, 2013
PubMed

Insights

Essential thrombocythemia (ET) involves Janus kinase 2 (JAK2V617F) mutations. This study found lower levels of PIAS1 and PIAS3, negative regulators of the JAK-STAT pathway, in ET patients, suggesting their role in the disease.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Essential thrombocythemia (ET) is a Philadelphia-negative myeloproliferative neoplasm.
  • The Janus kinase 2 (JAK2V617F) gain-of-function mutation is present in about half of ET patients.
  • The JAK-STAT pathway, activated by JAK2V617F, drives cell proliferation and survival.

Purpose of the Study:

  • To investigate the role of negative regulators of the JAK-STAT pathway, specifically Protein Inhibitors of Activated STAT (PIAS) and Suppressors of Cytokine Signaling (SOCS), in ET.
  • To compare the expression levels of PIAS1, PIAS3, SOCS1, and SOCS3 in ET patients with and without the JAK2V617F mutation against healthy controls.

Main Methods:

  • Quantitative-PCR was used to measure the expression levels of PIAS1, PIAS3, SOCS1, and SOCS3.
  • Study included 20 ET patients and 20 healthy individuals.
  • ET patients were genotyped for the JAK2V617F mutation.

Main Results:

  • PIAS1 and PIAS3 expression levels were significantly lower in ET patients compared to healthy individuals.
  • No significant difference in PIAS1 and PIAS3 expression was observed between ET patients with and without the JAK2V617F mutation.
  • Expression levels of SOCS1 and SOCS3 did not differ between ET patients and healthy individuals, nor between JAK2V617F positive and negative ET patients.

Conclusions:

  • Reduced expression of PIAS1 and PIAS3 may contribute to the pathomechanism of essential thrombocythemia.
  • These findings suggest that impaired negative regulation of the JAK-STAT pathway plays a role in ET pathogenesis.
  • Further research is warranted to explore the therapeutic potential of targeting these negative regulators in ET.

More Related Videos

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry08:07

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry

Published on: July 26, 2019

7.9K
Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

7.6K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
7.7K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K